LGGs with IDH wild‐type, 1p/19q non‐codeletion, and TERT mutation can progress to more aggressive gliomas, such as anaplastic glioma and secondary glioblastoma (GBM).7 The gene discussed is IDH2; the disease is central nervous system cancer.